Spectrophotometric blood analysis

• US 5,331,958 A
• Filed: 03/25/1993
• Issued: 07/26/1994
• Est. Priority Date: 03/31/1992
• Status: Expired due to Fees

• Current Assignee: Coretech Medical Technologies Corporation
• Original Assignee: University of Manitoba
• Inventors: Oppenheimer, Luis
• Primary Examiner(s): Sykes, Angela D.
• Application Number:
  US08/039,583
• Time in Patent Office: 488 Days
• Field of Search: 128/633-635, 128/637, 128/664-667, 128/632, 356/39-41
• US Class Current: 600/322
• CPC Class Codes: A61B 5/14535 for measuring haematocrit
• CPC Class Codes: A61B 5/14557 specially adapted to extracorporeal circuits
• CPC Class Codes: A61M 1/3609 Physical characteristics of the blood, e.g. haematocrit, urea
• CPC Class Codes: G01N 2015/055 for hematocrite determination
• CPC Class Codes: G01N 2021/0364 flexible, compressible
• CPC Class Codes: G01N 2021/3144 for oxymetry
• CPC Class Codes: G01N 21/532 with measurement of scattering and transmission

Abstract

A method and device are described which are particularly useful for continuous on-line monitoring of hematocrit and other blood parameters. The effect of change in blood electrolyte composition, for example, in blood sodium concentration, is taken into consideration. This effect has been found to change light beam geometry, and is taken advantage of to provide for blood sodium concentration measurement. The devices may be applied to extracorporeal circuits or to body parts capable of being transilluminated. The devices may be used to optimize dialysis, and also for monitoring optically detectable, exogenous macromolecules.

Claims

1. A method for optically determining blood parameters, said method comprising directing a light beam into a patient'"'"'s blood, detecting and measuring the light emerging from the blood, and compensating for any change in light beam geometry induced by any change in blood electrolyte composition.

2. The method of claim 1, wherein blood concentration of endogenous, optically detectable macromolecules is determined.

3. The method of claim 1, comprising eliminating the effect of blood oxygen saturation on said determination, wherein hematocrit is determined.

4. The method of claim 3, wherein an isobestic wavelength is selected.

5. The method of claim 1, further comprising directing into the blood, light of a wavelength selected to detect optically detectable macromolecules, and detecting emerging light of said wavelength.

6. The method of claim 1, wherein said electrolyte is sodium.

7. The method of claim 1, wherein said light beam is directed into an extracorporeal circuit containing flowing blood.

8. The method of claim 7, comprising returning the blood to the patient after said detecting step.

9. The method of claim 1, wherein detected changes in fluid balance are monitored to achieve fluid level management.

10. The method of claim 9, wherein in conjunction with said monitoring to achieve fluid level management, rate of fluid removal is regulated.

11. The method of claim 10, further comprising administering to the patient, a suitable therapeutic agent in an amount sufficient to assist fluid removal.

12. The method of claim 1, wherein blood oxygen content is determined.

13. The method of claim 1, comprising prior to said light detecting step, determining light beam geometry and selecting detectors located for sensitivity to change in light beam geometry.

14. A method for optically determining the blood concentration of macromolecules useful in evaluating exchange properties of blood vessels of a patient, comprising adding to the blood of the patient, a macromolecular mixture comprising a first macromolecular component characterized by a first vascular transport-affecting property and a first optically detectable property, and a second macromolecular component characterized by a second vascular transport-affecting property and a second optically detectable property, wherein said first and second transport-affecting properties differently affect transvascular transport, and wherein said first optically detectable property is optically distinct from said second optically detectable property;

and optically detecting change in blood concentration of at least one component of said macromolecular mixture, using a wavelength appropriate for each component determined.

15. The method of claim 14, wherein change in blood concentration of said first macromolecular component and of said second macromolecular component of said macromolecular mixture is optically detected, using a first wavelength appropriate for said first optically detectable property, and a second wavelength distinct from said first wavelength and appropriate for said second optically detectable property.

16. The method of claim 14, wherein said transvascular transport-affecting properties are selected from the group consisting of molecular weight, charge and rigidity.

17. A method for optically determining blood sodium concentration, said method comprising directing a light beam into a patient'"'"'s blood, detecting and measuring the light emerging from the blood, and evaluating any change in scatter of said light beam by comparison to a sodium reference, whereby an absolute blood sodium concentration may be obtained.

18. A device for optically determining blood parameters, said device comprising means for generating a light beam suitable for being directed into a patient'"'"'s blood;

first detecting means and second detecting means each disposed at a suitable location to be sensitive to any change in scatter of said light beam, but differently disposed with respect to said light beam;

sodium concentration reference means; and

signal evaluation means in operative communication with said first detecting means, said second detecting means, and said sodium concentration reference means.

19. The device of claim 18, wherein said detecting means are light detecting means, and wherein said location for said first detecting means provides for directly emerging light to be predominantly detected.

20. The device of claim 18, wherein a constant light path length is provided.

21. The device of claim 18, wherein said means for generating a light beam, emits an isobestic wavelength.